Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer

Carlos A. Castaneda; Henry L. Gómez

doi:10.3816/CBC.2009.n.046

Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer

Carlos A. Castaneda
, Henry L. Gómez

Instituto Nacional de Enfermedades Neoplásicas Eduardo Cáceres Graziani

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Resumen

Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor prognosis and short overall survival. We report a patient with advanced breast cancer without response to anthracyclines or taxanes but who controlled the disease for 15 months with the combination of ixabepilone and capecitabine.

Idioma original	Inglés
Páginas (desde-hasta)	E1-E3
Publicación	Clinical Breast Cancer
Volumen	9
N.º	4
DOI	https://doi.org/10.3816/CBC.2009.n.046
Estado	Publicada - 2009
Publicado de forma externa	Sí

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.3816/CBC.2009.n.046

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{dfa160a0f52f4520a43b1c28acc41dd6,

title = "Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer",

abstract = "Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor prognosis and short overall survival. We report a patient with advanced breast cancer without response to anthracyclines or taxanes but who controlled the disease for 15 months with the combination of ixabepilone and capecitabine.",

keywords = "Beta-tubulin, Capecitabine, Ixabepilone, MDR1",

author = "Castaneda, \{Carlos A.\} and G{\'o}mez, \{Henry L.\}",

year = "2009",

doi = "10.3816/CBC.2009.n.046",

language = "Ingl{\'e}s",

volume = "9",

pages = "E1--E3",

journal = "Clinical Breast Cancer",

issn = "1526-8209",

number = "4",

}

TY - JOUR

T1 - Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer

AU - Castaneda, Carlos A.

AU - Gómez, Henry L.

PY - 2009

Y1 - 2009

N2 - Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor prognosis and short overall survival. We report a patient with advanced breast cancer without response to anthracyclines or taxanes but who controlled the disease for 15 months with the combination of ixabepilone and capecitabine.

AB - Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor prognosis and short overall survival. We report a patient with advanced breast cancer without response to anthracyclines or taxanes but who controlled the disease for 15 months with the combination of ixabepilone and capecitabine.

KW - Beta-tubulin

KW - Capecitabine

KW - Ixabepilone

KW - MDR1

UR - https://www.scopus.com/pages/publications/73349098403

U2 - 10.3816/CBC.2009.n.046

DO - 10.3816/CBC.2009.n.046

M3 - Artículo

AN - SCOPUS:73349098403

SN - 1526-8209

VL - 9

SP - E1-E3

JO - Clinical Breast Cancer

JF - Clinical Breast Cancer

IS - 4

ER -